Medicare Enrolled
Dr. Preet Singh, MD
Hematology & Oncology · Springfield, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singh
Dr. Preet Singh is a hematology & oncology specialist in Springfield, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 29,415 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Singh received a total of $15,282 from 27 pharmaceutical and/or device companies across 79 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 27% volume in IL
$15,282 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗29,415
Medicare services
Top 27% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
22,440 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,656 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 820 | $1 | $79 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
707 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
591 | $92 | $554 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
586 | $1 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
450 | $8 | $82 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
369 | $6 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
298 | $96 | $679 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
237 | $12 | $88 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
194 | $13 | $118 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
150 | $22 | $155 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
134 | $11 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $60 | $376 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
85 | $46 | $311 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
84 | $2 | $5 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
76 | $200 | $1,130 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
70 | $21 | $149 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
67 | $48 | $319 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
60 | $24 | $149 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
59 | $10 | $103 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
58 | $15 | $98 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
44 | $130 | $783 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $116 | $741 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
18 | $5 | $58 |
| New patient office visit, complex (60-74 min) | 16 | $161 | $982 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $102 | $429 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
80.8% high complexity
12.8% medium
6.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,282
Total received (2018-2024)
Avg $2,183/year across 7 years
Top 25% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
79
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$964
2023
$352
2022
$14
2021
$34
2020
$3,202
2019
$4,681
2018
$6,036
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$173
Janssen Biotech, Inc.
$147
Astellas Pharma US Inc
$122
Novartis Pharmaceuticals Corporation
$97
Daiichi Sankyo Inc.
$83
Gilead Sciences, Inc.
$76
Merck Sharp & Dohme LLC
$60
Regeneron Healthcare Solutions, Inc.
$47
EMD Serono, Inc.
$44
JAZZ PHARMACEUTICALS INC.
$31
US Oncology Corporate, Inc.
$24
Mirati Therapeutics, Inc.
$18
Tempus AI, Inc
$15
PFIZER INC.
$14
Aveo Pharmaceuticals, Inc.
$13
Top 3 companies account for 45.8% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$6,036
Novartis Pharmaceuticals Corporation
$4,707
Incyte Corporation
$2,199
Rigel Pharmaceuticals, Inc.
$1,000
Janssen Biotech, Inc.
$176
AstraZeneca Pharmaceuticals LP
$173
Gilead Sciences, Inc.
$148
E.R. Squibb & Sons, L.L.C.
$133
Astellas Pharma US Inc
$122
Daiichi Sankyo Inc.
$109
Merck Sharp & Dohme LLC
$78
EMD Serono, Inc.
$71
Regeneron Healthcare Solutions, Inc.
$47
Mirati Therapeutics, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$31
Seagen Inc.
$27
Genmab U.S., Inc.
$26
US Oncology Corporate, Inc.
$24
Amgen Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Tempus AI, Inc
$15
Genentech, Inc.
$14
PFIZER INC.
$14
Celgene Corporation
$14
Aveo Pharmaceuticals, Inc.
$13
ADC Therapeutics America, Inc.
$11
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 84.7% of all-time payments
Associated products mentioned in payments ›
Avastin · BAVENCIO · CALQUENCE · DARZALEX · ELIQUIS · ENHERTU · ERLEADA · Enhertu · FOTIVDA · IMFINZI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Nplate · OPDIVO · OPDUALAG · PLUVICTO · Pomalyst · Stivarga · TAFINLAR · TECVAYLI · TUKYSA · Tavalisse · Tivdak · Trodelvy · Xospata · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
19
County median income
$74,114
Nearest hospital to ZIP centroid (approximate)
MEMORIAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Singh is a mixed practice specialist, with above-average Medicare volume (top 27% in IL), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Singh performed 22,440 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $15,282 from 27 companies across 79 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other hematology & oncology specialists in Springfield?
Dr. Singh's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Springfield
Browse hematology & oncology specialists in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology